 | Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Post Quarterly Sales of $22.08 Million
americanbankingnews.com - June 12 at 3:42 AM |
| Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4.1%
americanbankingnews.com - June 11 at 12:40 PM |
| Brokerages Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to Announce -$0.11 Earnings Per Share
americanbankingnews.com - June 10 at 9:18 AM |
| Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Recommendation of "Hold" by Brokerages
americanbankingnews.com - June 6 at 5:58 AM |
| -$0.10 EPS Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter
americanbankingnews.com - May 22 at 10:22 PM |
 | Rigel Appoints Alison L. Hannah, M.D. to Board of Directors
finance.yahoo.com - May 14 at 8:24 AM |
 | Rigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue Estimates
nasdaq.com - May 6 at 12:05 AM |
| Rigel Pharmaceuticals Inc. Bottom Line Rises In Q1
nasdaq.com - May 5 at 7:05 PM |
| Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Profit Outlook
finance.yahoo.com - April 20 at 1:19 PM |
| Is an EUA for Rigel’s COVID-19 Treatment in the Cards? Analyst Weighs In
finance.yahoo.com - April 16 at 10:27 PM |
|
 | Thinking about buying stock in Rigel Pharmaceuticals, Checkpoint Therapeutics, GT Biopharma, ICICI Bank, or Arbutus Biopharma?
marketwatch.com - April 13 at 10:51 PM |
 | Why Rigel Pharmaceuticals Stock Jumped Today
fool.com - April 13 at 5:38 PM |
 | Rigel Pharma Says Phase 2 Trial Of Fostamatinib For COVID-19 Met Primary Endpoint Of Safety
markets.businessinsider.com - April 13 at 7:49 AM |
| Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19
finance.yahoo.com - April 13 at 7:49 AM |
| Rigel Announces Closing of Strategic Collaboration with Lilly
finance.yahoo.com - April 7 at 8:54 AM |
| Rigel Completes Patient Enrollment In Phase 2 Trial To Evaluate Fostamatinib In COVID-19 Patients
markets.businessinsider.com - March 11 at 8:14 AM |
| Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
finance.yahoo.com - March 11 at 8:14 AM |
| Need To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
nasdaq.com - March 7 at 12:46 PM |
 | Rigel Pharmaceuticals' (RIGL) CEO Raul Rodriguez on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 4 at 9:54 AM |
| Rigel Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 3 at 8:41 AM |
| Need To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Revenues
finance.yahoo.com - March 3 at 8:16 AM |
| EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q4 Earnings Report
nasdaq.com - March 2 at 7:41 PM |
| Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 2 at 7:41 PM |
| 3 Penny Stocks Outpacing The Market This Week, Time To Buy?
marketwatch.com - February 25 at 1:28 AM |
| Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update
finance.yahoo.com - February 23 at 8:30 AM |
| 3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
finance.yahoo.com - February 21 at 7:48 AM |
|
| Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
nasdaq.com - February 19 at 1:27 PM |
 | RIGL Stock: Why Rigel Pharmaceuticals Is Climbing Today
investorplace.com - February 18 at 2:51 PM |
 | Peninsula biotech snares $125M upfront payment in drug deal with Lilly
bizjournals.com - February 18 at 2:34 PM |
 | Rigel Pharmaceuticals Rises on Drug Venture With Eli Lilly
thestreet.com - February 18 at 2:34 PM |
| Rigel Partners With Eli Lilly On Therapy For Autoimmune Disorders; Stock Pops 15%
finance.yahoo.com - February 18 at 2:34 PM |
| Why Rigel Pharmaceuticals Stock Is Jumping Today
finance.yahoo.com - February 18 at 2:34 PM |
| Lilly, Rigel To Develop RIPK1 Inhibitors For Treatment Of Immunological & Neurodegenerative Diseases
nasdaq.com - February 18 at 9:34 AM |
 | Rigel Higher on Immunology-Drug Venture With Eli Lilly
msn.com - February 18 at 9:34 AM |
| Rigel Pharma shares soar 39% premarket on news of deal with Eli Lilly
finance.yahoo.com - February 18 at 9:34 AM |
| UPDATE 1-Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 mln
finance.yahoo.com - February 18 at 9:34 AM |
| Rigel receives $16.5M for Phase 3 clinical trial of Fostamatinib in COVID-19 patients
seekingalpha.com - January 31 at 7:58 AM |
| Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
finance.yahoo.com - January 29 at 5:23 PM |
| If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You Could Pocket A 49% Gain Today
finance.yahoo.com - January 29 at 12:23 PM |
| Rigel Pharma Says TAVALISSE Preliminary 2020 Net Product Sales Up 41% - Quick Facts
markets.businessinsider.com - January 11 at 8:04 AM |
| Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 8:39 AM |
| Rigel Pharmaceuticals
fool.com - January 1 at 12:14 AM |
 | RIGL Feb 2021 5.000 call
uk.finance.yahoo.com - December 27 at 10:00 PM |
| RIGL Mar 2021 10.000 put
uk.finance.yahoo.com - December 27 at 10:00 PM |
| Is the Options Market Predicting a Spike in Rigel Pharmaceuticals (RIGL) Stock?
finance.yahoo.com - December 21 at 1:59 PM |
| Is RIGL A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 11:25 PM |
| What Type Of Shareholders Own The Most Number of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?
finance.yahoo.com - December 15 at 11:32 AM |
| Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition
finance.yahoo.com - December 4 at 8:57 AM |
| Health Canada OK's Rigel Pharma's Tavalisse for low blood platelets
seekingalpha.com - November 23 at 1:22 PM |
| Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia
finance.yahoo.com - November 23 at 8:21 AM |
